BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12460637)

  • 1. Cloning, pharmacological characterization, and polymorphism screening of the guinea pig beta(2)-adrenoceptor.
    Oostendorp J; Meurs H; Adriaan Nelemans S; Zaagsma J; Kauffman HF; Postma DS; Boddeke HW; Biber K
    Eur J Pharmacol; 2002 Dec; 457(1):1-10. PubMed ID: 12460637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mexiletine as an antagonist of beta-adrenoceptor in Chinese hamster ovary cells expressing cloned human beta-adrenoceptors.
    Sakamoto K; Karikomi Y; Kubota Y; Nakahara T; Ishii K
    Biochem Pharmacol; 2004 Mar; 67(5):815-22. PubMed ID: 15104234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
    Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of Tyr326 in the beta 2-adrenoceptor disrupt multiple receptor functions.
    Gabilondo AM; Krasel C; Lohse MJ
    Eur J Pharmacol; 1996 Jun; 307(2):243-50. PubMed ID: 8832227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
    Carter AA; Hill SJ
    J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors.
    Summerhill S; Stroud T; Nagendra R; Perros-Huguet C; Trevethick M
    J Pharmacol Toxicol Methods; 2008; 58(3):189-97. PubMed ID: 18652905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of beta1-adrenoceptors and mRNA expression of beta1- and beta2-adrenoceptors in guinea-pig esophagus.
    Horinouchi T; Tanaka Y; Koike K
    Eur J Pharmacol; 2003 Jul; 473(1):79-82. PubMed ID: 12877941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B; Allen GT
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A putative beta2-adrenoceptor from the rainbow trout (Oncorhynuchus mykiss). Molecular characterization and pharmacology.
    Nickerson JG; Dugan SG; Drouin G; Moon TW
    Eur J Biochem; 2001 Dec; 268(24):6465-72. PubMed ID: 11737201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional beta-2 adrenoceptor-mediated chronotropic response in isolated guinea pig heart tissue: selectivity of the potent beta-2 adrenoceptor agonist TA 2005.
    Voss HP; Shukrula S; Wu TS; Donnell D; Bast A
    J Pharmacol Exp Ther; 1994 Oct; 271(1):386-9. PubMed ID: 7965739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.
    Green SA; Turki J; Innis M; Liggett SB
    Biochemistry; 1994 Aug; 33(32):9414-9. PubMed ID: 7915137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor.
    Blin N; Nahmias C; Drumare MF; Strosberg AD
    Br J Pharmacol; 1994 Jul; 112(3):911-9. PubMed ID: 7921620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor.
    Patel S; Summerhill S; Stanley M; Perros-Huguet C; Trevethick MA
    Pulm Pharmacol Ther; 2011 Apr; 24(2):247-55. PubMed ID: 21134482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta3-Adrenergic regulation of an ion channel in the heart-inhibition of the slow delayed rectifier potassium current I(Ks) in guinea pig ventricular myocytes.
    Bosch RF; Schneck AC; Kiehn J; Zhang W; Hambrock A; Eigenberger BW; Rüb N; Gogel J; Mewis C; Seipel L; Kühlkamp V
    Cardiovasc Res; 2002 Dec; 56(3):393-403. PubMed ID: 12445880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracheal relaxing effects and beta2 adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues.
    Suzuki H; Ueno A; Takei M; Sindo K; Miura T; Sakakibara M; Higa T; Fukamachi H
    Br J Pharmacol; 1999 Oct; 128(3):716-20. PubMed ID: 10516653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacological characterization of high-affinity trimetoquinol analogs on guinea pig and human beta adrenergic receptor subtypes: evidence for partial agonism.
    Fraundorfer PF; Fertel RH; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1994 Aug; 270(2):665-74. PubMed ID: 7915318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.
    Slack RJ; Barrett VJ; Morrison VS; Sturton RG; Emmons AJ; Ford AJ; Knowles RG
    J Pharmacol Exp Ther; 2013 Jan; 344(1):218-30. PubMed ID: 23131596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.